Align Technology, US0162551016

Align Technology stock reacts to new board appointment and solid 2026 guidance

Published on 09/01/2026 at 22:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Align Technology stock trades in a stable range as investors digest the appointment of Quentin Blackford to the board and the company’s 2026 guidance and growth plans in clear aligners and digital dentistry.

Kieferorthopäde beim Intraoral-Scan, Schwarz-Weiß Reportage
Align Technology Inc. Schwarz-Weiß Reportagefoto eines Kieferorthopäden beim digitalen 3D-Scan eines Patienten US0162551016, Illustration mit AI erstellt.

Align Technology stock is in focus on September 1, 2026 as investors weigh a fresh board appointment against the backdrop of the company’s growth ambitions in clear aligners and digital orthodontics.

New director strengthens governance

Align Technology, Inc. (ISIN US0162551016) recently announced that its board of directors has appointed Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies, as a director effective August 31, 2026, while long-standing director Andrea Saia will retire from the board on September 23, 2026.

According to a Business Wire release carried by the Las Vegas Sun on August 31, 2026, Align Technology characterized the appointment as part of its ongoing effort to strengthen strategic oversight as the company expands its portfolio of the Invisalign System of clear aligners, iTero intraoral scanners and exocad CAD/CAM software.

Market backdrop and valuation context

On September 1, 2026, Align Technology stock continues to trade on the Nasdaq in United States dollars within a range that reflects investors’ mixed sentiment toward the wider medical-devices and dental-technology sector.

While intraday price data show the shares fluctuating modestly around their recent levels, the market capitalization remains firmly in the multibillion United States dollars bracket as of early September 2026, underlining Align’s status as one of the larger pure-play digital orthodontics companies globally.

Go deeper

More on Align Technology fundamentals

For more detailed figures, past earnings and regulatory disclosures on Align Technology, the ad-hoc-news.de topic page aggregates current coverage and official filings.

Clear aligners and digital dentistry portfolio

Align Technology generates the bulk of its revenue by designing, manufacturing and selling the Invisalign clear aligner system, which is used by orthodontists and general practitioners worldwide to correct malocclusion without traditional brackets and wires.

Complementing the aligner business, the company’s iTero intraoral scanners enable dentists to digitize the patient’s dentition and bite, providing precise input for treatment planning, while exocad CAD/CAM software supports restorative dentistry workflows and integrates with a wide range of dental laboratories and milling systems.

Stock perspective for retail investors

For retail investors following Align Technology stock, the current setup combines a governance catalyst in the form of a new director with a steady operational profile in orthodontics and digital dentistry as of September 1, 2026.

The shares continue to reflect expectations that Align will leverage its established Invisalign brand and expanding software and scanner ecosystem to drive growth in both developed and emerging markets over the coming years.

Align Technology stock at a glance

  • Company: Align Technology, Inc.
  • ISIN: US0162551016
  • Ticker: ALGN
  • Trading venue: NASDAQ
  • Sector / Industry: Health Care / Medical Devices
  • Index membership: S&P 500

Further videos and social discussion on Align Technology stock

Disclaimer...

en | US0162551016 | ALIGN TECHNOLOGY | boerse | 70039774 | bgmi